as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹147.12
Change
+3.35 (2.33%)
Open
₹143.0
Prev. Close
₹143.77
Day High
₹148.8
Day Low
₹143.0
Volume Analysis
Traded
106,923
Delivered
44,170
Delivery %
41.31%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (2)
- •Low return on equity (2.45%)
- •Below-average fundamentals quality score (39/100)
Opportunities (0)
No signal for this stock
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹155.42 | ₹152.11 | ₹149.62 | ₹146.31 | ₹143.82 | ₹140.51 | ₹138.02 |
| Fibonacci | ₹152.11 | ₹149.89 | ₹148.53 | ₹146.31 | ₹144.09 | ₹142.73 | ₹140.51 |
| Camarilla | ₹148.72 | ₹148.18 | ₹147.65 | ₹146.31 | ₹146.59 | ₹146.06 | ₹145.53 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-27.51%
1 Week
+6.36%
1 Month
-4.87%
3 Months
-16.28%
6 Months
+5.41%
1 Year
-40.47%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹85.13
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
3.68%
Net margin 3.23% × asset turnover 0.62x × equity multiplier 1.84x
Company Overview
Sector
Healthcare
Market Cap
₹1,589 Cr
P/E (TTM)
40.4
ROE
2.45%
Book Value
₹93.1
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 27 Sep 2026. Not investment advice.
TopFund Analysis
Shalby Limited scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 39/100. The strongest factor is Financial Strength (83/100), while Cash Flow (0/100) is the weakest area to weigh before deciding. Notably: Low return on equity (2.45%); below-average fundamentals quality score (39/100).
TopFund Score — Fundamentals Quality
39/100 — WeakData confidence: 78/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company's working capital requirements have reduced from 32.0 days to 21.7 days
- −Though the company is reporting repeated profits, it is not paying out dividend
- −Company has a low return on equity of 3.11% over last 3 years.
- −Dividend payout has been low at 5.11% of profits over last 3 years
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Shanay Vikram Shah’s Whole-time Director appointment failed at AGM; he ceased as Additional Director on September 10, 2026.
At September 10, 2026 AGM, resolutions 3 and 4 on Shanay Vikram Shah’s appointment were not passed.
Shalby shares FY26 annual report link and schedules 22nd AGM on 10 September 2026.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 235 | 238 | 216 | 244 | 279 | 268 | 276 | 265 | 296 | 285 | 272 | 287 | 331 |
| Expenses + | 192 | 185 | 174 | 205 | 234 | 235 | 242 | 244 | 255 | 244 | 242 | 258 | 290 |
| Operating Profit | 43 | 53 | 42 | 39 | 45 | 33 | 34 | 21 | 42 | 42 | 30 | 29 | 42 |
| OPM % | 18.0% | 22.0% | 20.0% | 16.0% | 16.0% | 12.0% | 12.0% | 8.0% | 14.0% | 15.0% | 11.0% | 10.0% | 13.0% |
| Other Income + | 5 | 5 | 5 | 5 | 10 | 7 | 5 | 5 | 7 | 4 | 7 | 8 | 7 |
| Interest | 3 | 3 | 4 | 6 | 8 | 9 | 11 | 11 | 9 | 10 | 11 | 9 | 11 |
| Depreciation | 12 | 12 | 12 | 16 | 16 | 17 | 16 | 16 | 17 | 17 | 18 | 18 | 19 |
| Profit before tax | 33 | 43 | 31 | 22 | 30 | 14 | 12 | -1 | 23 | 19 | 9 | 10 | 20 |
| Tax % | 37.0% | 35.0% | 38.0% | 26.0% | 52.0% | 83.0% | 124.0% | 1,547.0% | 66.0% | 62.0% | 86.0% | -92.0% | 47.0% |
| Net Profit + | 21 | 28 | 19 | 16 | 15 | 2 | -3 | -12 | 8 | 7 | 1 | 18 | 10 |
| EPS in Rs | 2 | 3 | 2 | 2 | 1 | 0 | 0 | -1 | 1 | 1 | 0 | 2 | 1 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 275 | 290 | 324 | 378 | 462 | 487 | 431 | 699 | 805 | 934 | 1,087 | 1,141 | 1,176 |
| Expenses + | 207 | 235 | 252 | 299 | 379 | 404 | 342 | 577 | 667 | 755 | 952 | 996 | 1,033 |
| Operating Profit | 68 | 56 | 71 | 79 | 83 | 83 | 89 | 122 | 138 | 179 | 135 | 145 | 143 |
| OPM % | 25.0% | 19.0% | 22.0% | 21.0% | 18.0% | 17.0% | 21.0% | 17.0% | 17.0% | 19.0% | 12.0% | 13.0% | 12.0% |
| Other Income + | 2 | 2 | 7 | 10 | 9 | 17 | 8 | 8 | 22 | 19 | 28 | 27 | 27 |
| Interest | 5 | 10 | 11 | 12 | 9 | 7 | 5 | 8 | 11 | 18 | 41 | 41 | 40 |
| Depreciation | 21 | 11 | 17 | 23 | 33 | 36 | 37 | 43 | 48 | 52 | 66 | 70 | 72 |
| Profit before tax | 43 | 36 | 50 | 54 | 50 | 57 | 55 | 79 | 102 | 128 | 56 | 61 | 58 |
| Tax % | 43.0% | -1.0% | 43.0% | 27.0% | 37.0% | 51.0% | 23.0% | 32.0% | 34.0% | 35.0% | 97.0% | 43.0% | — |
| Net Profit + | 25 | 36 | 29 | 39 | 32 | 28 | 42 | 54 | 68 | 84 | 2 | 35 | 38 |
| EPS in Rs | 7 | 4 | 3 | 4 | 3 | 3 | 4 | 5 | 6 | 8 | 1 | 3 | 4 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | 0.0% | 17.0% | 20.0% | 25.0% | 20.0% | 19.0% | 15.0% | 0.0% | 0.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 133 | 117 | 164 | 643 | 672 | 691 | 727 | 768 | 820 | 893 | 885 | 898 |
| Borrowings + | 98 | 224 | 328 | 114 | 71 | 62 | 44 | 155 | 180 | 378 | 476 | 595 |
| Other Liabilities + | 85 | 75 | 99 | 96 | 89 | 105 | 118 | 162 | 173 | 231 | 241 | 248 |
| Total Liabilities | 351 | 504 | 679 | 961 | 939 | 967 | 997 | 1,194 | 1,281 | 1,609 | 1,709 | 1,848 |
| Fixed Assets + | 175 | 319 | 323 | 650 | 692 | 672 | 660 | 675 | 685 | 966 | 955 | 1,046 |
| CWIP | 91 | 82 | 221 | 47 | 3 | 6 | 8 | 6 | 11 | 15 | 22 | 19 |
| Investments | 0 | 0 | 0 | 0 | 11 | 28 | 16 | 25 | 146 | 81 | 95 | 62 |
| Other Assets + | 85 | 102 | 134 | 264 | 233 | 260 | 314 | 488 | 440 | 547 | 637 | 721 |
| Total Assets | 351 | 504 | 679 | 961 | 939 | 967 | 997 | 1,194 | 1,281 | 1,609 | 1,709 | 1,848 |
| Equity Capital | 35 | 87 | 87 | 108 | 108 | 108 | 108 | 108 | 107 | 107 | 107 | 108 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | — | — | 60 | 14 | 43 | 55 | 79 | 19 | 68 | 20 | -4 | 0 |
| Cash from Investing Activity + | — | — | -153 | -236 | 1 | -31 | -51 | -60 | -61 | 146 | -36 | -97 |
| Cash from Financing Activity + | — | — | 96 | 222 | -51 | -22 | -30 | 90 | -50 | -151 | 48 | 84 |
| Net Cash Flow | — | — | 3 | 0 | -6 | 3 | -2 | 49 | -43 | 15 | 8 | -13 |
| CFO/OP | — | — | 99 | 34 | 63 | 91 | 99 | 34 | 70 | 22 | 7 | 27 |
| Free Cash Flow | — | — | -98 | -124 | 12 | 244 | 58 | -56 | 50 | -26 | -74 | -145 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Others | 0.87% | 0.83% | 0.76% | 0.7% | 0.69% | 0.69% | 0.69% | 0.69% | 0.66% | 0.66% | 0.66% | 0.65% |
| Public | 20.9% | 20.42% | 20.13% | 19.65% | 19.59% | 20.26% | 20.33% | 19.65% | 20.18% | 20.36% | 20.41% | 20.26% |
| Promoters | 74.12% | 74.12% | 74.24% | 74.25% | 74.25% | 74.27% | 74.27% | 74.27% | 74.33% | 74.33% | 74.33% | 74.33% |
| FII | 4.11% | 4.62% | 4.88% | 5.35% | 5.37% | 4.65% | 4.54% | 5.21% | 4.63% | 4.47% | 4.36% | 4.47% |
| DII | 0.0% | 0.0% | 0.0% | 0.06% | 0.09% | 0.14% | 0.18% | 0.19% | 0.19% | 0.19% | 0.25% | 0.3% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Shalby Limited (this stock) | 1,589 | 40.4 | 1.58 | 2.45% |
| Anlon Healthcare Limited | 1,655 | 52.3 | 7.18 | 18.4% |
| Amrutajan Health Ltd | 1,480 | 72.6 | 13.76 | 20.0% |
| Fermenta Biotech Ltd. | 1,455 | 26.6 | 3.58 | 16.4% |
| Tarsons Products Limited | 1,770 | 150.0 | 2.8 | 2.44% |
| Gujarat Kidney N Sup Sp L | 1,398 | 88.3 | 5.53 | 11.1% |
| Krsnaa Diagnostics Ltd | 1,785 | 18.3 | 1.81 | 10.9% |
Which Mutual Funds Hold Shalby Limited?
Frequently Asked Questions about Shalby Limited
Shalby Limited (SHALBY) closed at ₹147.12 on NSE on 25 September 2026, up 3.35 (2.33%) from the previous close.
Shalby Limited trades on the NSE (National Stock Exchange of India) under the symbol SHALBY.
Shalby Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 40.4.
Shalby Limited has a dividend yield of 0.0%.
Shalby Limited's 52-week high is ₹273.0 and its 52-week low is ₹126.0.
Shalby Limited has a market capitalisation of ₹1,589 crore.
Shalby Limited has a TopFund Quality Score of 39/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Shalby Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.